BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 30077809)

  • 1. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort
    Gillen M; Forte P; Svensson JO; Lamarca R; Burke J; Rask K; Larsdotter Nilsson U; Eckerwall G
    Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative Bioavailability of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Administered With and Without a Spacer: Results of a Phase I, Randomized, Crossover Trial in Healthy Adults.
    Dorinsky P; DePetrillo P; DeAngelis K; Trivedi R; Darken P; Gillen M
    Clin Ther; 2020 Apr; 42(4):634-648. PubMed ID: 32253054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.
    Ferguson GT; Tashkin DP; Skärby T; Jorup C; Sandin K; Greenwood M; Pemberton K; Trudo F
    Respir Med; 2017 Nov; 132():31-41. PubMed ID: 29229103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalent Lung Dose and Systemic Exposure of Budesonide/Formoterol Combination via Easyhaler and Turbuhaler.
    Lähelmä S; Sairanen U; Haikarainen J; Korhonen J; Vahteristo M; Fuhr R; Kirjavainen M
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):462-73. PubMed ID: 25757188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter.
    Shah S; White M; Uryniak T; O'Brien CD
    Allergy Asthma Proc; 2010; 31(1):40-8. PubMed ID: 20167144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of AeroChamber Plus™ on the lung and systemic bioavailability of beclometasone dipropionate/formoterol pMDI.
    Singh D; Collarini S; Poli G; Acerbi D; Amadasi A; Rusca A
    Br J Clin Pharmacol; 2011 Dec; 72(6):932-9. PubMed ID: 21615456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults.
    Darken P; DePetrillo P; Reisner C; St Rose E; Dorinsky P
    Pulm Pharmacol Ther; 2018 Jun; 50():11-18. PubMed ID: 29544728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD.
    Tronde A; Gillen M; Borgström L; Lötvall J; Ankerst J
    J Clin Pharmacol; 2008 Nov; 48(11):1300-8. PubMed ID: 18974284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
    Miller CJ; Senn S; Mezzanotte WS
    Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and Pharmacodynamic Comparison of Fluticasone Propionate/Formoterol Fumarate Administered via a Pressurized Metered-Dose Inhaler and a Novel Breath-Actuated Inhaler in Healthy Volunteers.
    Dissanayake S; Mundin G; Woodward J; Lomax M; Dalvi P
    J Aerosol Med Pulm Drug Deliv; 2023 Apr; 36(2):65-75. PubMed ID: 36796001
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD.
    Dunn LJ; Kerwin EM; DeAngelis K; Darken P; Gillen M; Dorinsky P
    Pulm Pharmacol Ther; 2020 Feb; 60():101873. PubMed ID: 31841699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant.
    Rony F; Cortellini M; Guasconi A; Mathews KS; Piccinno A; Poli G; Vanhoutte F; Klein J
    Pulm Pharmacol Ther; 2024 Jun; 85():102299. PubMed ID: 38663512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD.
    Kerwin EM; Siler TM; Arora S; Darken P; Rose E; Reisner C
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1483-1494. PubMed ID: 29773947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma scintigraphic pulmonary deposition study of glycopyrronium/formoterol metered dose inhaler formulated using co-suspension delivery technology.
    Taylor G; Warren S; Dwivedi S; Sommerville M; Mello L; Orevillo C; Maes A; Martin UJ; Usmani OS
    Eur J Pharm Sci; 2018 Jan; 111():450-457. PubMed ID: 29055732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro performance of valved holding chambers with a budesonide/formoterol pressurized metered-dose inhaler.
    Chambers FE; Brown S; Ludzik AJ
    Allergy Asthma Proc; 2009; 30(4):424-32. PubMed ID: 19772764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.
    Kosoglou T; Hubbell J; Xuan F; Cutler DL; Meehan AG; Kantesaria B; Wittmer BA
    Int J Chron Obstruct Pulmon Dis; 2013; 8():107-16. PubMed ID: 23525511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Exposures of Fluticasone Propionate and Salmeterol Following Inhalation via Metered Dose Inhaler with the Mini Spacer Compared with the Aerochamber Plus Spacer.
    Mehta R; Montembault M; Warren F; Gupta A; Brealey N; Moore A
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):386-92. PubMed ID: 26824933
    [TBL] [